NCT05665348 2026-03-09TRIPLETFederation Francophone de Cancerologie DigestivePhase 2/3 Completed229 enrolled
NCT05976568 2023-08-04A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaQilu Pharmaceutical Co., Ltd.Phase 2/3 Not yet recruiting668 enrolled